Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use. Vilsboll T, Stellfeld M, Aroda VR, Dandanell S, et al. Diabetes Obes Metab 2026;28:1499-1507.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vilsboll T, Stellfeld M, Aroda VR, Dandanell S, et al. Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use. Diabetes Obes Metab 2026;28:1499-1507.
PMID: 41287564